has approved
As of 2021, Canada has approved.) 3 cellular therapeutic products for patient use. These include using stem cells to treat acute lymphoblastic leukemia (ALL), Adult B-cell Lymphoma, and Graft V Host disease. There are thousands of other stem cell trials currently ongoing in the country.